The abnormality in enzyme metabolism system leads to many metabolic diseases that are related to components of enzyme metabolism system. Enzymes have been widely used in clinical examinaon as the preferred markers in various disease states such as myocardial infarcon, jaundice, pancreas, cancer, neurodegenerave disorders, etc. They provide insight through the ability of diagnosis, prognosis, and assessment of response therapy. https://www.creative-enzymes.com/promotions/Featured-Enzyme-Products-For-Diagnostic-Use_6.html
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
Featured Enzyme Products for Diagnosc Research
1. Email: info@crea ve-enzymes.com
Featured Enzyme Products for Diagnos c Research
The abnormality in enzyme metabolism system leads to many metabolic diseases that are
related to components of enzyme metabolism system. Enzymes have been widely used in
clinical examina on as the preferred markers in various disease states such as myocardial
infarc on, jaundice, pancrea s, cancer, neurodegenera ve disorders, etc. They provide
insight through the ability of diagnosis, prognosis, and assessment of response therapy.
Learn More
Product List
Cat No. EC No. Product Name Ac vity Appearance
DIA-135 EC 3.1.1.13
Na ve Microorganism
Cholesterol Esterase
5.0U/mg-solid or
more
Light brown
amorphous powder,
lyophilized
DIA-136 EC 1.1.3.6
Na ve Pseudomonas
sp. Cholesterol
Oxidase
15 U/mg-solid or
more(contg. approx.
40% of stabilizers)
Yellowish amorphous
powder, lyophilized
DIA-138 EC 1.1.3.6
Na ve Microorganism
Cholesterol Oxidase
12U/mg-solid or
more
Yellowish amorphous
powder, lyophilized
DIA-145 EC 1.1.1.49
Na ve Microorganism
Glucose-6-phosphate
Dehydrogenase
200U/mg-solid or
more
White amorphous
powder, lyophilized
DIA-181 EC 3.1.3.1
Na ve Microorganism
Alkaline phosphatase
Protein concentra on
is approximately 20
mg/ml.
Inquiry
DIA-182 EC 4.1.3.3
Na ve Microorganism
N-Acetylneuraminic
acid aldolase
15U/mg-solid or
more (30U/mg-
protein or more),
(containing approx.
30% of stabilizers)
Yellowish amorphous
powder, lyophilized
DIA-190 EC 3.2.1.3
Na ve Rhizopus sp.
Glucoamylase
30U/mg-solid or
more
White amorphous
powder (salt-free),
lyophilized
DIA-199 EC 1.1.3.21
Na ve Pediococcus sp.
L-α-glycerophosphate
oxidase
40 U/mg-solid or
more (containing
approx. 40% of
stabilizers)
Yellowish amorphous
powder, lyophilized
DIA-202 EC 2.7.1.1
Na ve Microorganism
Hexokinase
150U/mg-solid or
more
White amorphous
powder, lyophilized
DIA-208 EC 1.1.3.2
Na ve Microorganism
Lactate oxidase
80U/mg-solid or
more
Yellowish amorphous
powder, lyophilized
DIA-211 EC 3.1.1.34
Na ve Microorganism
Lipoprotein lipase
1.0U/mg-solid or
more
Light brown
amorphous powder,
lyophilized
DIA-213 EC 3.4.21.26
Na ve Flavobacterium
sp. Proline specific
endopep dase
5.0U/mg-solid or
more
White amorphous
powder, lyophilized
DIA-218 EC 1.1.3.22
Na ve Microorganism
Xanthine oxidase
10U/mg-solid or
more
Reddish brown
amorphous powder,
lyophilized
DIA-275 EC 1.6.99.-
Diaphorase from
microorganism
500U/mg-solid or
more
Inquiry
Crea ve Enzymes also provides other enzyme products for diagnos c use, in addi onal to
the ones listed above.
Learn More
Contact Informa on Email: info@crea ve-enzymes.com
45-1 Ramsey Road, Shirley, NY 11967, USA Tel: 1-631-562-8517
www.crea ve-enzymes.com Fax: 1-631-938-8127